These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 39290956)

  • 21. Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study.
    Kumar P; Kumar V; Murlidhar F; Fatima A; Jahangir M; Khalid D; Memon MK; Memon S; Kumar B
    Cureus; 2021 May; 13(5):e14788. PubMed ID: 34094750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
    Li PC; Huang RY; Yang YC; Hsieh KP; Yang YH
    BMC Cancer; 2022 Apr; 22(1):430. PubMed ID: 35443635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
    Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
    JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
    Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
    BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
    Zhang P; Zhu L; Cai J; Lei F; Qin JJ; Xie J; Liu YM; Zhao YC; Huang X; Lin L; Xia M; Chen MM; Cheng X; Zhang X; Guo D; Peng Y; Ji YX; Chen J; She ZG; Wang Y; Xu Q; Tan R; Wang H; Lin J; Luo P; Fu S; Cai H; Ye P; Xiao B; Mao W; Liu L; Yan Y; Liu M; Chen M; Zhang XJ; Wang X; Touyz RM; Xia J; Zhang BH; Huang X; Yuan Y; Loomba R; Liu PP; Li H
    Circ Res; 2020 Jun; 126(12):1671-1681. PubMed ID: 32302265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged >70 Years) and Octogenarians with Systolic Heart Failure.
    Sargento L; Simões AV; Longo S; Lousada N; Dos Reis RP
    Drugs Aging; 2016 Sep; 33(9):675-83. PubMed ID: 27568454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Renin-Angiotensin System Inhibitors on the Treatment of Metastatic Renal Cancer.
    Saeedi N; Mansoori S; Asgharzadeh F; Soleimani A; Mollazadeh S; Hasanian SM
    Curr Pharm Des; 2023 May; ():. PubMed ID: 37226780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin System Inhibitors and Development of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
    Asgharzadeh F; Jafarzadeh-Esfehani R; Hassanian SM; Ferns GA; Avan A; Khazaei M
    Curr Pharm Des; 2020; 26(39):5079-5085. PubMed ID: 32660400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - A population-based cohort study in Taiwan.
    Kao YT; Huang CY; Fang YA; Liu JC
    Int J Cardiol; 2020 Apr; 305():147-153. PubMed ID: 31955975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and community-acquired pneumonia: A nationwide population propensity-score matching study.
    Lin SY; Chang SS; Lin CL; Lin CC; Hsu WH; Chou CH; Chi CY; Lin CD; Tu CY; Hsu CY; Kao CH
    Int J Clin Pract; 2021 Oct; 75(10):e14476. PubMed ID: 34107133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
    J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review.
    Mc Menamin ÚC; Murray LJ; Cantwell MM; Hughes CM
    Cancer Causes Control; 2012 Feb; 23(2):221-30. PubMed ID: 22116540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT.
    King JB; Berchie RO; Derington CG; Marcum ZA; Scharfstein DO; Greene TH; Herrick JS; Jacobs JA; Zheutlin AR; Bress AP; Cohen JB
    J Am Heart Assoc; 2023 Sep; 12(17):e030311. PubMed ID: 37646208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia.
    Armstrong EJ; Chen DC; Singh GD; Amsterdam EA; Laird JR
    Vasc Med; 2015 Jun; 20(3):237-44. PubMed ID: 25835349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis.
    Du YH; Guan CJ; Li LY; Gan P
    Ann Palliat Med; 2022 Mar; 11(3):1093-1101. PubMed ID: 35365039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R; Rios P; Baldovinos G; Chichet MA; Perg N; Sola L; Saona G; De Souza N; Lamadrid V; Gadola L
    Nephron; 2019; 143(2):100-107. PubMed ID: 31203280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.
    ARB Trialists Collaboration
    J Hypertens; 2011 Apr; 29(4):623-35. PubMed ID: 21358417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke.
    Chang KC; Lin CH; Huang JA
    J Am Heart Assoc; 2024 Sep; 13(17):e035438. PubMed ID: 39189618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea.
    Jung MH; Lee JH; Lee CJ; Shin JH; Kang SH; Kwon CH; Kim DH; Kim WH; Kim HL; Kim HM; Cho IJ; Cho I; Hwang J; Ryu S; Kang C; Lee HY; Chung WJ; Ihm SH; Kim KI; Cho EJ; Sohn IS; Park S; Shin J; Ryu SK; Rhee MY; Kang SM; Pyun WB; Cho MC; Sung KC
    J Clin Hypertens (Greenwich); 2021 Apr; 23(4):879-887. PubMed ID: 33492766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.